相似文献
1
Revisiting the Diabetes-Heart Failure Connection.
Curr Diab Rep. 2018 Oct 20;18(12):134. doi: 10.1007/s11892-018-1116-z.
2
Diabetes Mellitus and Heart Failure.
Am J Cardiol. 2017 Jul 1;120(1S):S37-S47. doi: 10.1016/j.amjcard.2017.05.014. Epub 2017 May 30.
3
Diabetes Mellitus and Heart Failure.
Am J Med. 2017 Jun;130(6S):S40-S50. doi: 10.1016/j.amjmed.2017.04.010.
4
Heart Failure in Type 2 Diabetes Mellitus.
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.
5
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data.
Biomed Res Int. 2017;2017:1253425. doi: 10.1155/2017/1253425. Epub 2017 Aug 15.
6
Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.
Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 8.
7
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
J Card Fail. 2019 Aug;25(8):584-619. doi: 10.1016/j.cardfail.2019.05.007. Epub 2019 Jun 5.
8
Effect of glucose-lowering therapies on heart failure.
Nat Rev Cardiol. 2018 May;15(5):282-291. doi: 10.1038/nrcardio.2017.211. Epub 2018 Jan 25.
9
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus.
JACC Heart Fail. 2018 Oct;6(10):813-822. doi: 10.1016/j.jchf.2018.05.020. Epub 2018 Aug 8.
10
Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.
Expert Rev Cardiovasc Ther. 2018 Feb;16(2):123-131. doi: 10.1080/14779072.2018.1423962. Epub 2018 Jan 9.
引用本文的文献
1
Applying an Improved Stacking Ensemble Model to Predict the Mortality of ICU Patients with Heart Failure.
J Clin Med. 2022 Oct 31;11(21):6460. doi: 10.3390/jcm11216460.
2
Diabetes and Heart Failure: Multi-Omics Approaches.
Front Physiol. 2021 Aug 6;12:705424. doi: 10.3389/fphys.2021.705424. eCollection 2021.
3
Insomnia symptoms and incident heart failure: a population-based cohort study.
Eur Heart J. 2021 Oct 21;42(40):4169-4176. doi: 10.1093/eurheartj/ehab500.
4
Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates.
Commun Biol. 2021 Feb 12;4(1):188. doi: 10.1038/s42003-021-01676-3.
本文引用的文献
1
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med. 2018 Aug 16;379(7):633-644. doi: 10.1056/NEJMoa1800256.
2
Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials.
JACC Basic Transl Sci. 2018 Jun 25;3(3):415-419. doi: 10.1016/j.jacbts.2018.04.003. eCollection 2018 Jun.
3
Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure.
Diabetes Obes Metab. 2018 Nov;20(11):2653-2660. doi: 10.1111/dom.13448. Epub 2018 Jul 30.
4
Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
Artif Cells Nanomed Biotechnol. 2018;46(sup2):1015-1024. doi: 10.1080/21691401.2018.1478420. Epub 2018 Jun 6.
5
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Circ Res. 2018 Feb 16;122(4):624-638. doi: 10.1161/CIRCRESAHA.117.311586.
6
Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.
Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 8.
7
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.
Heart Fail Rev. 2018 May;23(3):419-437. doi: 10.1007/s10741-017-9665-9.
8
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
Circulation. 2017 Oct 17;136(16):1548-1559. doi: 10.1161/CIRCULATIONAHA.117.030418.
9
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13.
10
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.
Zotero 插件